Monday Nov 28, 2022

Selecting Medication for Depression: Do Genomics Matter? - Frankly Speaking Ep 304

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit:

Overview: Pharmacogenomic testing has been suggested as a way to personalize medicine, particularly where the metabolism of medications can vary significantly. Unfortunately, despite increasing use of this testing, there has been little evidence showing a benefit in clinical outcomes. Listen to this podcast to explore the data on clinical outcomes for pharmacogenetic testing and how to best select medication for patients with depression.

Episode resource links:

  • Oslin DW, Lynch KG, Shih MC, et al. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA. 2022;328(2):151-161.

Guest: Alan Ehrlich MD, FAAFP
Music Credit: Richard Onorato

Copyright 2022 All rights reserved.

Version: 20221013